title: Comment on: prescribing of rosiglitazone and pioglitazone following safety signals analysis of trends in dispensing patterns in The Netherlands from 1998 to 2008.
authors.affiliation: Santiago of Compostela Health Area, Galician Health Service (Servizo Galego de Saude (Sergas)), Spanish National Health System, Apartado de Correos 466, Santiago de Compostela, A Coruña, Spain, eduardo.carracedo.martinez@sergas.es.
authors.forename: Eduardo
authors.initials: E
authors.lastname: Carracedo-Martínez
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008297:Male; D010818:Practice Patterns, Physicians' / Q000639:trends*; D045162:Thiazolidinediones / Q000008:administration & dosage*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones